Effect of Cold Application on Pain and Bruising in Patients With Subcutaneous Injection of Low-Molecular-Weight Heparin: A Meta-Analysis
To evaluate the effect of cold application on pain and bruising after the subcutaneous injection of low-molecular-weight heparin, 8 electronic databases were searched for randomized controlled trials and quasiexperimental studies from the inception of the databases to June 2019. Review Manager 5.3 software was used for the heterogeneity test and meta-analysis. A total of 8 studies including 694 participants were analyzed. The cold application group assessed with the Verbal Descriptor Scale pain assessment tool showed significant reductions in pain intensity immediately after injection. Compared to the control group, the cold application group showed a reduction in the occurrence of bruises at 12 hours, 24 hours, and 48 hours after injection. There was no significant difference in the area of bruising in the cold application group at 48 hours after injection, but the area of bruising at 72 hours after injection was significantly reduced. These results show that cold application can reduce the incidence of pain and bruising after subcutaneous injection of low-molecular-weight heparin and reduce the area of bruising 72 hours after injection. Additional studies with larger sample sizes are needed to confirm these findings..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Clinical and Applied Thrombosis/Hemostasis - 26(2020) |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Haifeng Wang BA [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1177/1076029620905349 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ016838858 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ016838858 | ||
| 003 | DE-627 | ||
| 005 | 20230502131240.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/1076029620905349 |2 doi | |
| 035 | |a (DE-627)DOAJ016838858 | ||
| 035 | |a (DE-599)DOAJ98d2807e5575473dad3235b9c161d0d3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC666-701 | |
| 100 | 0 | |a Haifeng Wang BA |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of Cold Application on Pain and Bruising in Patients With Subcutaneous Injection of Low-Molecular-Weight Heparin: A Meta-Analysis |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a To evaluate the effect of cold application on pain and bruising after the subcutaneous injection of low-molecular-weight heparin, 8 electronic databases were searched for randomized controlled trials and quasiexperimental studies from the inception of the databases to June 2019. Review Manager 5.3 software was used for the heterogeneity test and meta-analysis. A total of 8 studies including 694 participants were analyzed. The cold application group assessed with the Verbal Descriptor Scale pain assessment tool showed significant reductions in pain intensity immediately after injection. Compared to the control group, the cold application group showed a reduction in the occurrence of bruises at 12 hours, 24 hours, and 48 hours after injection. There was no significant difference in the area of bruising in the cold application group at 48 hours after injection, but the area of bruising at 72 hours after injection was significantly reduced. These results show that cold application can reduce the incidence of pain and bruising after subcutaneous injection of low-molecular-weight heparin and reduce the area of bruising 72 hours after injection. Additional studies with larger sample sizes are needed to confirm these findings. | ||
| 653 | 0 | |a Diseases of the circulatory (Cardiovascular) system | |
| 700 | 0 | |a Jingjing Guan MD |e verfasserin |4 aut | |
| 700 | 0 | |a Xiaohan Zhang MD |e verfasserin |4 aut | |
| 700 | 0 | |a Xinxin Wang MD |e verfasserin |4 aut | |
| 700 | 0 | |a Tianliang Ji MD |e verfasserin |4 aut | |
| 700 | 0 | |a Dandan Hou MD |e verfasserin |4 aut | |
| 700 | 0 | |a Guiru Wang BA |e verfasserin |4 aut | |
| 700 | 0 | |a Jiao Sun PhD |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Clinical and Applied Thrombosis/Hemostasis |d SAGE Publishing, 2020 |g 26(2020) |w (DE-627)DOAJ078594448 |x 19382723 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2020 |
| 856 | 4 | 0 | |u https://doi.org/10.1177/1076029620905349 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/98d2807e5575473dad3235b9c161d0d3 |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1177/1076029620905349 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1938-2723 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2020 | ||